Tests:Procalcitonin: Difference between revisions

Tests:Procalcitonin
Created page with "{{DISPLAYTITLE: Procalcitonin}} Full Test List Biochemistry Tests {| class="wikitable" ! colspan="2" | === ''Overview'' === |- |Department |Biochemistry |- |Test Code |PCTN |- |Synonyms |PCT PCTN   |- |Turnaround Time |2 hours |- |Stability – Add test |8 hours unseparated   48 hours when separated from the cells and/or gel |- ! colspan="2" | === ''Specimen Requirements'' === |- |Specimen Type |Plasma Serum |- |Specimen Transportation |..."
 
Updated method Alinity
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{DISPLAYTITLE: Procalcitonin}}   
{{DISPLAYTITLE: Procalcitonin, Plasma}}   


[[Category:Tests]]  
[[Category:Tests]]  
Line 6: Line 6:
{| class="wikitable"
{| class="wikitable"
! colspan="2" |
! colspan="2" |
=== ''Overview'' ===
== Overview ==
|-
|-
|Department  
|Department  
Line 18: Line 18:


PCTN    
PCTN    
|-
|Availability
|Monday - Sunday, testing routinely available out of hours
|-
|-
|Turnaround Time  
|Turnaround Time  
Line 28: Line 31:
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Specimen Requirements'' ===
== Specimen Requirements ==
|-
|-
|Specimen Type
|Specimen  
|Plasma
|Plasma


Serum
Serum
|-
|Specimen Transportation
|
|-
|-
|Preferred  
|Preferred  
Line 42: Line 42:
|-
|-
|Acceptable  
|Acceptable  
|Plain <span style="background:#e30022"> Red-Top</span>   
|6 mL Plain <span style="background:#e30022"> Red-Top</span>   
|-
|Unacceptable
|Grossly haemolysed samples
|-
|Specimen Transportation
|
|-
|-
|Pediatric Requirements    
|Paediatric Requirements    
|600 µL <span style="background:#99e6b3"> Li-Hep Microtainer </span>    
|600 µL <span style="background:#99e6b3"> Li-Hep Microtainer </span>    
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Aliquot Requirements'' ===
== Aliquot Requirements ==
|-
|-
|Sample Type
|Sample  
|Serum  
|Serum  


Line 65: Line 71:
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Clinical Information'' ===
== Clinical Information ==
|-
|-
|Reference Intervals  
|Reference Intervals  
|There are two ranges: Standard ranges and associated comments, and ranges for neonates within the first 48hrs after birth.  
|There are two ranges: Standard ranges and associated comments, and ranges for neonates within the first 48hrs after birth.  


 
 ''Standard ranges:''  
 
'''''Standard ranges:'''''  


'''''PCT <0.5 ng/mL''''' – Systemic infection (sepsis) is unlikely.  Local bacterial infection is possible.  
'''''PCT <0.5 ng/mL''''' – Systemic infection (sepsis) is unlikely.  Local bacterial infection is possible.  
Line 82: Line 86:
'''''PCT >10 ng/mL''''' – Important SIRS almost exclusively due to bacterial sepsis or septic shock.  
'''''PCT >10 ng/mL''''' – Important SIRS almost exclusively due to bacterial sepsis or septic shock.  


 
 ''Neonate ranges:''  
 
'''''Neonate ranges:'''''  
{| class="wikitable"
{| class="wikitable"
|Age in hours
|Age in hours
Line 112: Line 114:
|-
|-
|Test Method  
|Test Method  
|Abbott Alinity Ci analyser, using Abbott reagents.    
|Abbott Alinity i series analyser using Abbott reagents.  Chemiluminescent microparticle immunoassay.
|-
|-
|Advanced Notice  
|Advanced Notice  
Line 121: Line 123:
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Comments'' ===
== Comments ==
|-
|-
| colspan="2" |PCT levels can be increased in certain circumstances without infectious origin.  These include, but are not limited to:  
| colspan="2" |PCT levels can be increased in certain circumstances without infectious origin.  These include, but are not limited to:  


Prolonged or severe cardiogenic shock  
* Prolonged or severe cardiogenic shock  
 
* Prolonged severe organ perfusion anomalies  
Prolonged severe organ perfusion anomalies  
* Small cell lung cancer or medullary C-cell carcinoma of the thyroid  
 
* Early after major trauma, major surgery intervention, severe burns  
Small cell lung cancer or medullary C-cell carcinoma of the thyroid  
* Treatments which stimulate the release of pro-inflammatory cytokines
 
Early after major trauma, major surgery intervention, severe burns  
 
Treatments which stimulate the release of pro-inflammatory cytokines  
|}
|}
{{DocMeta
| owner = Crossley1
| review_ping =
}}
<!-- review-ping: 2026-09-14T08:14:30.627Z -->